Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ANTXR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
EID2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
WDR59 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PAXBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BTBD9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101927446 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERICH1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RIMKLB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SRSF8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
AFG3L1P - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TOX4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LSM11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2J1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATRAID - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAVS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on